{
    "2021-08-31": [
        [
            {
                "time": "",
                "original_text": "东吴证券维持智飞生物买入评级，2021半年报点评：新冠疫苗贡献显著业绩，原有业务保持快速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "业绩增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "超八成深市公司上半年盈利，新能源产业链表现抢眼",
                "features": {
                    "keywords": [
                        "深市公司",
                        "新能源",
                        "盈利"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深市创业板2021年半年度业绩持续高速增长",
                "features": {
                    "keywords": [
                        "深市创业板",
                        "半年度业绩",
                        "高速增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金连续7日净买入8月累计加仓270亿，中国平安逆势遭抛售超20亿",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "中国平安",
                        "抛售"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中航证券给予智飞生物买入评级，2021年中报点评：业绩超预期，新冠疫苗或成新增长极",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "业绩超预期",
                        "买入评级"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：IVD政策落地好于预期 国产疫苗数据全球瞩目",
                "features": {
                    "keywords": [
                        "医药行业",
                        "IVD政策",
                        "国产疫苗",
                        "数据瞩目"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【预见】上半年净利润飙增265%！股价大涨近8%！智飞生物前景如何？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润增长",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}